Resources with keywords: covid-19
Sinovac vaccine phase 1/2 clinical trial results
This project is supported by McGill University Interdisciplinary Initiative in Infection and Immunity (MI4). The COVID19 Vaccine Tracker is designed to provide clear, accessible, and comprehensive updates about COVID19 vaccine development and approvals worldwide. It includes links to phase 1, phase 2, phase 3 clinical trials.
Updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines
Lindsley WG, Derk RC, Coyle JP, et al.
A combination of HEPA air cleaners and universal masking reduced exposure by up to 90%.
The U.K. is one of the first governments to set out provisional plans for booster shots. It isconcerned that possible further Covid-19 outbreaks over the winter could coincide with awave of influenza and put pressure on the country’s health system
This page includes various groups at risk of developing severe disease including pregnant women
Table including the status of COVID-19 Vaccines within WHO EUL/PQ evaluation process
Walach H, Weikl R, Prentice J, et al.
A large-scale survey3 in Germany of adverse effects in parents and children using data of 25 930 children has shown that 68% of the participating children had problems when wearing nose and mouth coverings.
This analysis of publicly available data on publications, preprints, and clinical trials coupled with the Global Health Security Index measure of dual-use oversight suggests that some research activities raise dualuse concerns that have gone unaddressed.
